H Kumar1, P K Gupta2, M Jaiprakash3. 1. Professor and Head, Armed Forces Medical College, Pune. 2. Associate Professor (Department of Transfusion Medicine), Armed Forces Medical College, Pune. 3. Dy Director General (Provision), O/o DGAFMS, Ministry of Defence, New Delhi.
Abstract
BACKGROUND: Transfusion transmitted hepatitis B has always been a dreaded disease, with incidence of increased transmission through donated blood. The screening test for hepatitis B infection is detection of HBsAg that does not rule out the risk of transmission of hepatitis B as the donor may be in the 'window period'. During this period, detection of the antibody to the hepatitis B core antigen (anti-HBc) IgM type serves as a useful serological marker. The aim of this study was to screen blood donors for anti-HBc type IgM and anti - HBc Ag total for detection and to find their incidence amongst blood donors. METHODS: 2552 voluntary blood donors were screened by the ELISA method for HBsAg and anti - HBc IgM and other mandatory screening markers. 704 of the test blood samples were also screened for anti-HBc total. RESULT: Of the 2552 donor, 47 (1.84 %) cases were HBsAg positive. A total of 11 (0.43 %) blood units were reactive for HBcAg IgM and of these, 10 (0.39 %) were HBsAg negative and reactive for anti-HBcAg IgM. Of the 704 samples tested for anti - HBcAg total, 112 (15.9%) samples were reactive. CONCLUSION: Screening of blood for anti-HBc total is practical in the western world as the incidence of HBsAg and anti-HBc is low in these countries and these positive blood units for anti - HBcAg total can be discarded. This may not be practical in India as the incidence of anti- HBcAg total is high in our population. It is recommended that all blood units should be tested for anti - HBc IgM for infectivity status of the blood donors in the window period and to discard blood if positive.
BACKGROUND: Transfusion transmitted hepatitis B has always been a dreaded disease, with incidence of increased transmission through donated blood. The screening test for hepatitis B infection is detection of HBsAg that does not rule out the risk of transmission of hepatitis B as the donor may be in the 'window period'. During this period, detection of the antibody to the hepatitis B core antigen (anti-HBc) IgM type serves as a useful serological marker. The aim of this study was to screen blood donors for anti-HBc type IgM and anti - HBc Ag total for detection and to find their incidence amongst blood donors. METHODS: 2552 voluntary blood donors were screened by the ELISA method for HBsAg and anti - HBc IgM and other mandatory screening markers. 704 of the test blood samples were also screened for anti-HBc total. RESULT: Of the 2552 donor, 47 (1.84 %) cases were HBsAg positive. A total of 11 (0.43 %) blood units were reactive for HBcAg IgM and of these, 10 (0.39 %) were HBsAg negative and reactive for anti-HBcAg IgM. Of the 704 samples tested for anti - HBcAg total, 112 (15.9%) samples were reactive. CONCLUSION: Screening of blood for anti-HBc total is practical in the western world as the incidence of HBsAg and anti-HBc is low in these countries and these positive blood units for anti - HBcAg total can be discarded. This may not be practical in India as the incidence of anti- HBcAg total is high in our population. It is recommended that all blood units should be tested for anti - HBc IgM for infectivity status of the blood donors in the window period and to discard blood if positive.
Entities:
Keywords:
Anti hepatitis B core antigen; Hepatitis B surface antigen; Window period
Authors: C E Stevens; R D Aach; F B Hollinger; J W Mosley; W Szmuness; R Kahn; J Werch; V Edwards Journal: Ann Intern Med Date: 1984-12 Impact factor: 25.391
Authors: J W Mosley; C E Stevens; R D Aach; F B Hollinger; L T Mimms; L R Solomon; L H Barbosa; G J Nemo Journal: Transfusion Date: 1995-01 Impact factor: 3.157
Authors: Mutiat K Ogunfemi; Hannah O Olawumi; Abdulfatai B Olokoba; Modu B Kagu; Sikiru A Biliaminu; Kabir A Durowade; Idayat A Durotoye; Akeem O Shittu Journal: Malawi Med J Date: 2017-03 Impact factor: 0.875